I. Introduction: A Trillion-Dollar "Invisible" Industry
You may have heard of artificial intelligence, semiconductors, and commercial spaceflight, but the term "biomanufacturing" is quietly becoming a core part of national strategy.
Tan Tianwei, academician of the Chinese Academy of Engineering and president of Beijing University of Chemical Technology, offered a concise definition: bio-manufacturing is a new industrial production method centered on biological reactions, characterized primarily by greenness, efficiency, and recyclability.
Producing steel with microbes, growing fabrics with cells, and cultivating collagen through fermentation—these scenarios that sound like science fiction are becoming reality. It is predicted that by 2030, China's bio-manufacturing industry will grow to a total scale of 1.8 trillion yuan. Behind this transformation lies an industrial logic broader than AI and more fundamental than new energy.
II. Underlying Logic: How Does Biofabrication Reshape Production Methods?
The core of biofabrication is not "what to make," but "how to make it."
Traditional industries rely on high-temperature and high-pressure chemical synthesis and physical processing, consuming vast amounts of fossil fuels and emitting large quantities of carbon dioxide. In contrast, bio-manufacturing uses microorganisms or enzymes as "production workshops" to carry out synthesis reactions under normal temperature and pressure.
Academician Tan Tianwei gave several vivid examples:
Tea polyphenols: Drinking tea to obtain tea polyphenols requires consuming large amounts of tea daily. However, through biotechnology, the active ingredients in tea leaves can be highly concentrated into精华 (essence), significantly transforming both consumption methods and costs.
Synthetic fabrics: Traditional synthetic fibers are made from petroleum, and their production generates significant carbon emissions. In contrast, bio-based fabrics are produced at ambient temperature and pressure, meeting clothing needs while reducing carbon emissions.
Metallurgy: Specific microorganisms have now been identified that can reduce metal oxides to metals under ambient temperature and pressure. Compared to traditional high-temperature blast furnace metallurgy, this represents a revolutionary advancement.
These three examples correspond to the three levels of bio-manufacturing: from "extraction" to "synthesis," from "chemical" to "biological," and from "high temperature and high pressure" to "ambient temperature and pressure." Each leap across these layers represents a systematic reconfiguration of traditional production methods.
III. Health for All: When Expensive "Luxuries" Become "Daily Necessities"
The healthcare sector represents the scenario where biomanufacturing is closest to commercialization.
Academician Tan Tianwei revealed that many common chemically synthesized drugs, such as antihypertensive medications, can now be produced through biomanufacturing, significantly reducing production costs while being more environmentally friendly and low-carbon.
Wild Cordyceps: Highly sought after, but its harvesting causes significant damage to natural ecosystems. Biomanufacturing can enable industrial-scale production of its beneficial components while substantially reducing costs.
Collagen and hyaluronic acid—key ingredients in medical aesthetics and skincare products—have traditionally been extracted from animals and plants, making them expensive. Biomanufacturing can significantly lower production costs, dramatically reducing the prices of common beauty products such as skincare creams and eye serums.
Core logic: Biomanufacturing is transforming "scarce resources" into "scalable industrial products." As a growing number of nutritional supplements and drugs become more affordable and accessible, a broader population will benefit.
Four: China's Advantages: An Industrial Foundation Built on Three "World Firsts"
Academician Tan Tianwei analyzed the competitiveness of China's bio-manufacturing industry from three dimensions:
First, China leads the world in fermentation capacity. The country's fermentation industry accounts for about 70% of global industrial capacity and fermentation tank volume. This unique capability provides a solid foundation that is difficult for other countries to replicate in the short term.
Second, a super-large market. The public's aspiration for a better life and rising purchasing power are genuine and foreseeable, creating a vast market with enormous potential. Products from bio-manufacturing—from health supplements to new materials—naturally benefit from an existing domestic demand base.
Third, research and development momentum is world-leading. China ranks first globally in both the number of biomanufacturing papers published internationally and patents filed. Although this does not entirely equate to technological leadership, it indicates that China has already developed initial research capabilities and R&D momentum to advance to a higher stage.
5. Track Breakdown: Three Investment Themes
The market size of bio-manufacturing exceeds 1.8 trillion, encompassing areas far beyond what most people imagine. For early-stage investors, the following three directions are particularly worth focusing on:
5.1 Synthetic Biology Platform
By utilizing gene editing, metabolic engineering, and other techniques, "cell factories" capable of efficiently producing target compounds are engineered. This represents the upstream segment of the biomanufacturing industry chain and involves the highest technological barriers. Key focus areas include the capability to construct "chassis cells" and product conversion efficiency.
5.2 Bio-based Materials and Fine Chemicals
From biodegradable plastics to biofuels, from high-end skincare ingredients to functional food additives, bio-based materials are increasingly replacing petroleum-based products in the market. The key focus lies in the speed of cost reduction—whether costs can be brought down to levels comparable to or even lower than those of conventional chemical processes.
5.3 Biopharmaceuticals and Nutritional Health
Biomanufacturing is transforming the way drugs are produced and nutrients are delivered. From antihypertensive medications to cordyceps alternatives, from collagen to functional food ingredients, this sector offers both B2B raw material supply opportunities and B2C brand potential. Key factors include regulatory barriers and consumer acceptance.
6. Insights for Investors
6.1 Biomanufacturing is not a "story," but a "reality unfolding now"
The investment logic of the biomanufacturing industry differs from that of early-stage AI or the metaverse—it features real production capacity, actual revenue, and tangible cost reduction curves. The fact that fermentation capacity accounts for 70% of global output is not a concept, but a physically existing industrial infrastructure.
6.2 Opportunities for "Dimensional Disruption" in Traditional Industries
The greatest investment value of bio-manufacturing lies not in creating a "new industry," but in replacing production methods across multiple traditional sectors. Metallurgy, textiles, chemicals, pharmaceuticals, food, and cosmetics—each of these trillion-dollar markets could see their cost structures and competitive landscapes reshaped by bio-manufacturing.
6.3 Focus on Three Key Metrics
Cost Curve: The ultimate competitiveness of biological manufacturing lies in whether it can be cheaper than traditional methods.
Scale-up capability: Just because a lab can "make it" doesn't mean a factory can "produce it." Pilot-scale expansion and mass production represent the biggest "valley of death" in biomanufacturing.
Policies and Standards: As biomanufacturing products enter traditional sectors, they often face challenges such as lack of standards and regulatory delays. Companies that take the lead in shaping these standards will gain institutional advantages.
VII. Conclusion
With a market size of 1.8 trillion, accounting for 70% of global fermentation capacity, and spanning applications from metallurgy to cosmetics—biomanufacturing is not merely a "future industry," but rather an ongoing industrial paradigm shift.
The insight of Academician Tan Tianwei of the Chinese Academy of Engineering is worth deep reflection: from raw materials to processes, from products to daily life, bio-manufacturing is weaving an invisible network that connects people with a greener, smarter, and more sustainable future. Though this transformation unfolds quietly, it is powerful enough to usher in a new era of green manufacturing.
For investors, understanding the underlying logic of bio-manufacturing may be more important than chasing any single "trend"—because it's not a trend, but rather the foundation.
